Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma

NCT02190838 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

57

Enrollment

OTHER

Sponsor class

Stopped Preliminary terminated due to inefficacy

Conditions

Melanoma

Interventions

DRUG: Metformin
DRUG: Melatonin
DRUG: Dacarbazine

Sponsor

N.N. Petrov National Medical Research Center of Oncology